بنام خداوند جان وخرد. Antimicrobial Agents 2 Murray: ch 17 Jawets: ch 28 Dr Alvandi.

Slides:



Advertisements
Similar presentations
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Advertisements

PHL 424 Antimicrobials 9 th Lecture By Abdelkader Ashour, Ph.D. Phone:
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
FLUOROQUINOLONES Ciprofloxacin Norfloxacin Ofloxacin Pefloxacin CIPROFLOXACIN Mechanism of action Inhibit DNA synthesis by inhibiting DNA gyrase.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case Microbiology.
MECHANISMS OF ACTION OF ANTIBIOTICS. BACTERIOSTATIC AGENTS Sulfonamides Drugs inhibiting protein synthesis except aminoglycosides (macrolides, chloramphenicol,
Antibiotics Review 10 August :39 AM.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Antibiotic Mechanisms of Action and Resistance MLAB 2434 – Microbiology Keri Brophy-Martinez.
Drugs acting on bacterial protein biosynthesis
Protein synthesis inhibitors: M.Sc. In Pharm (Pharmacology)
Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.
Antimicrobial compounds Antiseptics and disinfectants Antibiotics.
1 Inhibitors of Protein Synthesis Bacterial cells are 50% protein by dry weight –Inhibition of protein synthesis leads to cessation of growth or cell death.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 85 Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines,
Quinolones Folic Acid Antagonists Urinary Tract Antiseptics.
Antimicrobial Medications (Part I) Supplemental instruction Designed by Pyeongsug Kim ©2010 Fall 2010 For Dr. Wright’s Bio 7/27.
ANTIMICROBIAL DRUGS-2 Presented by: Sarbeel Al Mosddar.
By: Azreena (D11A005) & Nur Nabila (D11A027)
Antibiotic Resistance The Miracle Revoked? Wilson “Bill” Muse 10/29/2009.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Ch 20: Antimicrobial Drugs ChemotherapyThe use of drugs to treat a disease Antimicrobial drugsInterfere with the growth of microbes within a host AntibioticSubstance.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 90 Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole,
© 2004 Wadsworth – Thomson Learning Chapter 21 Pharmacology.
Batterjee Medical College. Dr. Manal El Said Department Head of Microbiology Antimicrobial Drugs: Mechanism of Action.
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
ANTIMICROBIAL AGENTS. ANTIBIOTICS ANTIMICROBIAL AGENTS CHEMOTHERAPEUTIC AGENTS.
Antimicrobial agents.
Antibiotics; Inhibitors of Protein and DNA Synthesis LECTURE 11: Microbiology and Virology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences.
Macrolides. The macrolides are a group of closely related compounds characterized by a macrocyclic lactone ring (usually containing 14 or 16 atoms) to.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, Clindamycin, Linezolid,
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
Treatment of Infectious Diseases. ›Drugs used to treat bacterial diseases are grouped into categories based on their modes of action Treatment of Bacterial.
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
INHIBITOR of BACTERIAL PROTEIN SYNTHESIS. BACTERIAL PROTEIN SYNTHESIS The selectivity for bacterial protein synthesis is caused by differences in the.
Microbial DNA Synthesis Inhibitors Quinolones; fluoroquinolones Most widely used antibiotics in 2002 but their use has been recently reduced due to toxicity,
Ciprofloxacin (most common) Norfloxacin
Ariana Hurtado Garcia Medico Interno.  Quinolones were first developed in the 1960s and can be classified into generations based on antimicrobial activity.
Antibiotics (anti-microbials)
PRINCIPLES OF ANTIBIOTIC THERAPY
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others.
Protein Synthesis Inhibitors. TETRACYCLINES MACROLIDES CLINDAMYCIN CHLORAMPHENICOL STREPTOGRAMINS OXAZOLIDINONES.
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
DNA gyrase inhibitors Quinolones
Antibiotic versus chemotherapeutic agent
Protein Synthesis Inhibitors
ANTIMICROBIAL AGENTS.
Chapter 20 Antimicrobial Medications
Antimicrobial Agents Antibiotics:
Intro to Antibiotics By: Alaina Darby.
By :Lecturer Nabeel Ahmed Al anbagi
Inhibitors of Protein Synthesis
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Anti-Microbial Agents Anti-bacterial (antibiotics)
Fluoroquioblones صيدلانية نظري / د . فارس رابع صيدلة 23 / 4 / 2016
by Dr.Sawsan Sajid & Dr. Ibtesam G.Auda
Chapter 20 Antibacterial Agents
Chloramphenicol as protein synthesis inhibitor
Broad-spectrum antibiotics
Chemotherapeutic Medicine
Synthetic antimicrobial drugs
Other Protein Synthesis Inhibitor
2- Tetracyclines Classification
ANTIBIOTICS They are divided into four categories based on their bacteriostatic or bactericidal effect(mode of action) on various structures and macromolecules.
Presentation transcript:

بنام خداوند جان وخرد

Antimicrobial Agents 2 Murray: ch 17 Jawets: ch 28 Dr Alvandi

Resistance to aminoglycosides (1) mutation of the ribosomal binding site (1) mutation of the ribosomal binding site (2) decreased uptake of the antibiotic into the bacterial cell, (2) decreased uptake of the antibiotic into the bacterial cell, (3) increased expulsion of the antibiotic from the cell (3) increased expulsion of the antibiotic from the cell (4) enzymatic modification of the antibiotic. (4) enzymatic modification of the antibiotic. –aminoglycoside phosphotransferase [APHs] seven described), – adenyltransferases (adenine nucleotide translocases [ANTs]; four described) –acetyltransferases (acetyl-CoA carboxylases [AACs]; ]; four described

Tetracyclines

bacteriostatic binding reversibly to the 30S ribosomal subunits, thus blocking the binding of aminoacyl-tRNA to the 30S ribosome–mRNA complex

Resistance to the tetracyclines Decreased penetration Decreased penetration Active efflux Active efflux alteration of the ribosomal target site alteration of the ribosomal target site enzymatic modification of the antibiotic. enzymatic modification of the antibiotic.

Glycylclines Tigecycline has a higher binding affinity for the ribosome and is less affected by efflux or enzymatic modification has a higher binding affinity for the ribosome and is less affected by efflux or enzymatic modification broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria, broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria, although Proteus, Morganella, Providencia, and P. aeruginosa are generally resistant. although Proteus, Morganella, Providencia, and P. aeruginosa are generally resistant.

Oxazolidinones Narrow-spectrum Narrow-spectrum Linezolid Linezolid binds to the 30S ribosomal subunit and blocks initiation of protein synthesis binds to the 30S ribosomal subunit and blocks initiation of protein synthesis activity against all staphylococci, streptococci, and enterococci activity against all staphylococci, streptococci, and enterococci

Chloramphenicol broad antibacterial spectrum broad antibacterial spectrum disrupts protein synthesis in human bone marrow cells and can produce blood dyscrasias, such as aplastic anemia disrupts protein synthesis in human bone marrow cells and can produce blood dyscrasias, such as aplastic anemia binding reversibly to the peptidyl transferase component of the 50S ribosomal subunit, thus blocking peptide elongation. binding reversibly to the peptidyl transferase component of the 50S ribosomal subunit, thus blocking peptide elongation.

Resistance to chloramphenicol plasmid-encoded chloramphenicol acetyl transferase plasmid-encoded chloramphenicol acetyl transferase

Macrolides Reversible binding to the 23S ribosomal RNA (rRNA) of the 50S ribosomal subunit which blocks polypeptide elongation. Reversible binding to the 23S ribosomal RNA (rRNA) of the 50S ribosomal subunit which blocks polypeptide elongation. bacteriostatic antibiotics bacteriostatic antibiotics broad spectrum of activity broad spectrum of activity

Resistance to macrolides methylation of the 23S rRNA methylation of the 23S rRNA inactivation of the macrolides by enzymes (e.g., esterases, phosphorylases, glycosidase) inactivation of the macrolides by enzymes (e.g., esterases, phosphorylases, glycosidase) mutations in the 23S rRNA and ribosomal proteins. mutations in the 23S rRNA and ribosomal proteins.

Ketolides: Telithromycin semisynthetic derivative of erythromycin semisynthetic derivative of erythromycin binds to the 50S ribosomal subunit and blocks protein synthesis binds to the 50S ribosomal subunit and blocks protein synthesis Resistance: Mutations in 23S rRNA or the ribosomal proteins Resistance: Mutations in 23S rRNA or the ribosomal proteins

Telithromycin cont… good activity against staphylococci good activity against staphylococci S. pneumoniae, other respiratory pathogens (e.g., H. influenzae, Moraxella catarrhalis) S. pneumoniae, other respiratory pathogens (e.g., H. influenzae, Moraxella catarrhalis) gram-positive rods, gram-positive rods, some anaerobes except B. fragilis some anaerobes except B. fragilis Good activity against intracellular pathogens (e.g., Legionella, Mycoplasma, Chlamydia, Chlamydiophila ), Rickettsia, Bartonella, Coxiella, Francisella, and M. avium. Good activity against intracellular pathogens (e.g., Legionella, Mycoplasma, Chlamydia, Chlamydiophila ), Rickettsia, Bartonella, Coxiella, Francisella, and M. avium.

lincosamide: Clindamycin blocks protein elongation by binding to the 50S ribosome by inhibiting peptidyl transferase blocks protein elongation by binding to the 50S ribosome by inhibiting peptidyl transferase interfering with the binding of the amino acid–acyl-tRNA complex. interfering with the binding of the amino acid–acyl-tRNA complex. Clindamycin is active against staphylococci and anaerobic gram-negative rods Clindamycin is active against staphylococci and anaerobic gram-negative rods Methylation of the 23S rRNA is the source of bacterial resistance Methylation of the 23S rRNA is the source of bacterial resistance.

cyclic peptides: group A and B Streptogramins quinupristin-dalfopristin quinupristin-dalfopristin Dalfopristin binds to the 50S ribosomal subunit and induces a conformational change that facilitates binding of quinupristin. Dalfopristin binds to the 50S ribosomal subunit and induces a conformational change that facilitates binding of quinupristin. Dalfopristin prevents peptide chain elongation, and quinupristin initiates premature release of peptide chains from the ribosome. Dalfopristin prevents peptide chain elongation, and quinupristin initiates premature release of peptide chains from the ribosome.

INHIBITION OF NUCLEIC ACID SYNTHESIS

Quinolones and Fluoroquinolones: Mechanism of activity inhibit bacterial DNA topoisomerase type II (gyrase) or topoisomerase type IV, which are required for DNA replication, recombination, and repair inhibit bacterial DNA topoisomerase type II (gyrase) or topoisomerase type IV, which are required for DNA replication, recombination, and repair

Resistance Resistance to the quinolones is mediated by chromosomal mutations in the structural genes for DNA gyrase and topoisomerase type IV Resistance to the quinolones is mediated by chromosomal mutations in the structural genes for DNA gyrase and topoisomerase type IV decreased drug uptake decreased drug uptake Overexpression of efflux pumps that actively eliminate the drug Overexpression of efflux pumps that actively eliminate the drug

Fluoroquinolones Adverse Effects Gastrointestinal – 5 % Gastrointestinal – 5 %  Nausea, vomiting, diarrhea, dyspepsia Central Nervous System Central Nervous System  Headache, agitation, insomnia, dizziness, rarely, hallucinations and seizures (elderly) Hepatotoxicity Hepatotoxicity  LFT elevation (led to withdrawal of trovafloxacin) Phototoxicity (uncommon with current FQs) Phototoxicity (uncommon with current FQs)  More common with older FQs (halogen at position 8) Cardiac Cardiac  Variable prolongation in QTc interval  Led to withdrawal of grepafloxacin, sparfloxacin

Fluoroquinolones Adverse Effects Articular Damage Articular Damage  Arthopathy including articular cartilage damage, arthralgias, and joint swelling  Observed in toxicology studies in immature dogs  Led to contraindication in pediatric patients and pregnant or breastfeeding women  Risk versus benefit Other adverse reactions: tendon rupture, dysglycemias, hypersensitivity Other adverse reactions: tendon rupture, dysglycemias, hypersensitivity

Rifampin and Rifabutin binds to DNA dependent RNA polymerase and inhibits the initiation of RNA synthesis. binds to DNA dependent RNA polymerase and inhibits the initiation of RNA synthesis. Rifampin is bactericidal for Mycobacterium tuberculosis Rifampin is bactericidal for Mycobacterium tuberculosis mutation in the beta subunit of RNA pol mutation in the beta subunit of RNA pol Rifabutin: particularly active against M. avium Rifabutin: particularly active against M. avium

Metronidazole effective in the treatment of amebiasis, giardiasis, and serious anaerobic bacterial infections (including those caused by B. fragilis). effective in the treatment of amebiasis, giardiasis, and serious anaerobic bacterial infections (including those caused by B. fragilis).

Metronidazole: Mechanisms of activity The antimicrobial properties of metronidazole stem from the reduction of its nitro group by bacterial nitroreductase, thereby producing cytotoxic compounds that disrupt the host DNA. The antimicrobial properties of metronidazole stem from the reduction of its nitro group by bacterial nitroreductase, thereby producing cytotoxic compounds that disrupt the host DNA.

Metronidazole: Resistance Resistance results either from decreased uptake of the antibiotic Resistance results either from decreased uptake of the antibiotic elimination of the cytotoxic compounds before they can interact with bacterial DNA. elimination of the cytotoxic compounds before they can interact with bacterial DNA.

Clofazimine Clofazimine: lipophilic antibiotic that binds to mycobacterial DNA. It is highly active against M. tuberculosis, Clofazimine: lipophilic antibiotic that binds to mycobacterial DNA. It is highly active against M. tuberculosis, first-line drug for the treatment of Mycobacterium leprae first-line drug for the treatment of Mycobacterium leprae

Pyrazinamide (PZA) Pyrazinamide (PZA) is active against M. tuberculosis at a low pH, such as that found in phagolysosomes Pyrazinamide (PZA) is active against M. tuberculosis at a low pH, such as that found in phagolysosomes The mechanism by which PZA exerts its effect is unknown.